newsfilter
← Latest News
Business Wire·

Blade Therapeutics Appoints Accomplished Biopharmaceutical Executive, Mark Timney, as Chairman of the Board

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Blade Therapeutics, a leader in the fields of fibrosis, COVID-19 pathogenesis and inflammatory biology, today announced the appointment of Mark Timney as Chairman of the Board of Directors. Mr. Timney succeeds Luke Evnin, Ph.D., co-founder and Managing Director of MPM, who has served as Chairman since the founding of Blade Therapeutics in 2015. Dr. Evnin will remain a member the Board of Directors, which will expand by one member.